New e-tool helps R.Ph.s advise dual eligibles on Medicare
Tags: MEDICAL telematics; MEDICAL informatics; DRUGS -- Prescribing; PHARMACISTS; OLDER people -- Medical care; MEDICARE; MEDICAID
Related Articles
- Should the House Approve H.R. 1, the Medicare Prescription Drug, Improvement, and Modernization Act? Con. // Congressional Digest;Feb2004, Vol. 83 Issue 2, p53
Presents an opposing view on the new H.R.1, the Medicare Prescription Drug, Improvement, and Modernization Act in the United States. Enactment of a Medicare bill that bows to major drug companies preventing Medicare from negotiating better prices; Concentration on privatization and higher...
- Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Zermansky, Arnold G; Petty, Duncan R; Raynor, David K; Lowe, Catherine J; Freemantle, Nick; Vail, Andy // BMJ: British Medical Journal (International Edition);12/8/2001, Vol. 323 Issue 7325, p1340
Abstract Objective: To determine whether a pharmacist can effectively review repeat prescriptions through consultations with elderly patients in general practice. Design Randomised controlled trial comparing clinical medication review by a pharmacist against normal general practice review....
- Campaign begins for Medicare drug coverage. Wechsler, Jill // Managed Healthcare Executive;Sep2005, Vol. 15 Issue 9, p12
Reports on insurers, pharmacy benefit managers (PBM) and health plans' marketing campaigns to attract and enroll older people in Part D Medicare prescription drug plans (PDP). Insurers' offering of stand-alone and Medicare Advantage prescription drug plans (MA-PD); Official period for the Part D...
- Carriers Will Consider All Diagnosis Codes On CMS Claims. // Getting Paid in Behavioral Healthcare;Sep2006, Vol. 11 Issue 9, p4
The article reports that the U.S. Centers for Medicare & Medicaid Services (CMS) has required carriers to alter their claims processing system. It was stated that the Multi-Carriers System is designed to process diagnosis information that providers report about their claims for Medicare payment...
- Drug Plans Spring Past "Fall Back" Wechsler, Jill // Pharmaceutical Executive;Apr2005, Vol. 25 Issue 4, p24
Reports on the projection of market growth with Medicare subsidizing pharmacy benefits in the U.S. Drug price negotiation between the Centers for Medicare and Medicaid Services and the pharmaceutical marketers; Review and approval process of prescription drug plans; Coverage of medicine used by...
- Coordinated Care for Dual-Eligibles: Minnesota Senior Health Options. Parker, Pam; Sander, Amy // Policy & Practice of Public Human Services;Dec2001, Vol. 59 Issue 4, p26
Discusses medical care options for senior citizens eligible for both Medicaid and Medicare in Minnesota. Market-based managed care service delivery model; Role of risk adjustment in plan participation; Development of chronic care systems.
- State Initiatives to Integrate the Medicare and Medicaid Programs for Dually Eligible Beneficiaries. Grabowski, David C.; Bramson, Jeffrey // Generations;Fall2008, Vol. 32 Issue 3, p54
Poor coordination of benefits and services from Medicare and Medicaid has been a long-standing problem in care for the population eligible for both programs. Now, state initiatives to integrate these programs are providing potential models of coordinated care for our troubled healthcare system.
- Reducing hospitalizations of nursing home residents. Yap, Diana // Pharmacy Today;Nov2012, Vol. 18 Issue 11, p68
The article reports that pharmacist involvement was proposed for four of the seven projects in a $100 million dual eligibles initiative of the U.S. Centers for Medicare and Medicaid Services (CMS). It notes that the initiative aims to reduce avoidable hospitalizations among nursing facility...
- Should the House Approve H.R. 1, the Medicare Prescription Drug, Improvement, and Modernization Act? Con. // Congressional Digest;Feb2004, Vol. 83 Issue 2, p55
Presents a strongly opposing viewpoint to the Medicare Prescription Drug, Improvement, and Modernization Act. Offer of huge tax cuts to the richest Americans with no proper relief from the high cost of prescription drugs to seniors; Non-satisfaction of the immediate need for drug benefit to...
